BioStock: Neola initiates usability study ahead of FDA approval

Report this content

Lund-based Neola Medical continues to advance towards clinical studies with its lung monitoring system. The company is now starting a usability study – an important part of the process to be able to launch the product in the US. BioStock spoke to CEO Hanna Sjöström to find out more about the study.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/03/neola-initiates-usability-study-ahead-of-fda-approval/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: Neola initiates usability study ahead of FDA approval
Tweet this